Zimmer Biomet Holdings (ZBH) Gross Profit (2009 - 2026)

Zimmer Biomet Holdings' Gross Profit history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• On a quarterly basis, Gross Profit rose 11.12% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $5.9 billion, a 7.67% increase from a year earlier, with the FY2025 full-year figure at $5.7 billion, up 4.56% from the prior year.
• Gross Profit advanced to $1.5 billion in Q1 2026 per ZBH's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Gross Profit topped out at $1.5 billion in Q1 2026 and bottomed at $1.2 billion in Q1 2022.
• The 5-year median for Gross Profit is $1.4 billion (2025), against an average of $1.4 billion.
• Across the five-year window, Gross Profit rose 14.36% in 2023 and dropped 1.28% in 2025, its largest moves.
• Year by year, Gross Profit stood at $1.3 billion in 2022, then grew by 7.4% to $1.4 billion in 2023, then gained by 2.51% to $1.4 billion in 2024, then advanced by 1.04% to $1.5 billion in 2025, then climbed by 4.07% to $1.5 billion in 2026.
• Per Business Quant, the three latest ZBH Gross Profit figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025).